8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
May 1, 2026·SEC
Material company update
Apr 14, 2026·SEC
Corteva, Inc.(CTVA)Earnings, Financials & Key Ratios
CTVA•NYSE
$83.91
$56.33B mkt cap·52.4× P/E·Price updated May 6, 2026
AboutCorteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.Show more
- Revenue$17.4B+2.9%
- EBITDA$3.82B+15.0%
- Net Income$1.09B+20.6%
- EPS (Diluted)1.60+23.1%
- Gross Margin43.59%-0.1%
- EBITDA Margin21.96%+11.8%
- Operating Margin15.05%+21.4%
- Net Margin6.29%+17.2%
- ROE4.52%+22.8%
- ROIC8.53%+32.2%
- Debt/Equity0.11-5.9%
- Interest Coverage10.38+60.3%
CTVA Key Insights
Corteva, Inc. (CTVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FCF machine: 16.2% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Share count reduced 3.3% through buybacks
- ✓Trading near 52-week high
✗Weaknesses
- ✗Weak 3Y average ROE of 3.7%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CTVA Price & Volume
Corteva, Inc. (CTVA) stock price & volume — 10-year historical chart
Loading chart...
CTVA Growth Metrics
Corteva, Inc. (CTVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years4.12%
3 Years-0.1%
TTM6.27%
Profit CAGR
10 Years-
5 Years9.94%
3 Years-1.56%
TTM1.93%
EPS CAGR
10 Years-
5 Years11.95%
3 Years0.42%
TTM3.63%
Return on Capital
10 Years3.86%
5 Years6.33%
3 Years7.25%
Last Year8.56%
CTVA Recent Earnings
Corteva, Inc. (CTVA) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 4/12 qtrs (33%)
Q1 2026Latest
Feb 3, 2026EPS
$0.22
Est $0.22
-1.3%
Revenue
$3.9B
Est $4.2B
-7.8%
Q4 2025
Nov 4, 2025EPS
$0.23
Est $0.51
+54.6%
Revenue
$2.6B
Est $2.5B
+6.0%
Q3 2025
Aug 6, 2025EPS
$2.20
Est $1.89
+16.4%
Revenue
$6.5B
Est $6.3B
+3.0%
Q2 2025
May 7, 2025EPS
$1.13
Est $0.87
+29.3%
Revenue
$4.4B
Est $4.5B
-2.8%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 3, 2026 | $0.22vs $0.22-1.3% | $3.9Bvs $4.2B-7.8% |
| Q4 2025 | Nov 4, 2025 | $0.23vs $0.51+54.6% | $2.6Bvs $2.5B+6.0% |
| Q3 2025 | Aug 6, 2025 | $2.20vs $1.89+16.4% | $6.5Bvs $6.3B+3.0% |
| Q2 2025 | May 7, 2025 | $1.13vs $0.87+29.3% | $4.4Bvs $4.5B-2.8% |
Based on last 12 quarters of dataView full earnings history →
CTVA Peer Comparison
Corteva, Inc. (CTVA) competitors in Seeds and crop genetics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 FMC | 1.86B | 14.87 | -0.83 | -18.34% | -72.93% | -82.27% | 2.00 | |
 CF | 19.97B | 128.04 | 19.00 | -10.48% | 20.47% | 17.92% | 8.78% | 0.43 |
 MOS | 7.38B | 23.26 | 5.99 | 5.03% | 10.46% | 9.99% | 0.06 | |
 NTR | 37.33B | 77.24 | 16.30 | 5.33% | 8.44% | 8.97% | 5.46% | 0.51 |
 AMGN | 177.87B | 329.59 | 23.16 | 9.92% | 20.95% | 89.41% | 4.55% | 6.31 |
 AVD | 83.98M | 2.95 | -1.69 | -5.88% | -9.68% | -22.89% | 0.99 | |
 DD | 20.18B | 49.23 | -26.47 | -44.7% | -0.41% | -0.21% | 5.35% | 0.23 |
 DOW | 29.36B | 40.80 | -11.06 | -6.97% | -7.02% | -15.35% | 1.12 |
Compare CTVA vs Peers
Corteva, Inc. (CTVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CTVA Income Statement
Corteva, Inc. (CTVA) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 14.24B | 14.29B | 13.85B | 14.22B | 15.65B | 17.45B | 17.23B | 16.91B | 17.4B | 17.89B |
| Revenue Growth % | - | 0.33% | -3.09% | 2.68% | 10.11% | 11.5% | -1.31% | -1.85% | 2.92% | 6.27% |
| Cost of Goods Sold | 8.4B | 9.95B | 8.57B | 8.51B | 9.22B | 10.44B | 9.92B | 9.53B | 9.82B | 6.99B |
| COGS % of Revenue | 59% | 69.63% | 61.93% | 59.84% | 58.89% | 59.79% | 57.59% | 56.36% | 56.41% | - |
| Gross Profit | 5.84B▲ 0% | 4.34B▼ 25.7% | 5.27B▲ 21.5% | 5.71B▲ 8.3% | 6.43B▲ 12.7% | 7.02B▲ 9.1% | 7.31B▲ 4.1% | 7.38B▲ 1.0% | 7.58B▲ 2.8% | 6B▲ 0% |
| Gross Margin % | 41% | 30.37% | 38.07% | 40.16% | 41.11% | 40.21% | 42.41% | 43.64% | 43.59% | 33.51% |
| Gross Profit Growth % | - | -25.68% | 21.48% | 8.33% | 12.7% | 9.08% | 4.09% | 1% | 2.79% | - |
| Operating Expenses | 5.65B | 4.79B | 4.69B | 4.87B | 5.12B | 5.09B | 5.2B | 5.28B | 4.97B | 5.46B |
| OpEx % of Revenue | 39.68% | 33.51% | 33.85% | 34.23% | 32.69% | 29.17% | 30.16% | 31.25% | 28.54% | - |
| Selling, General & Admin | 2.97B | 3.04B | 3.06B | 3.04B | 3.21B | 3.17B | 3.18B | 3.2B | 3.49B | 3.62B |
| SG&A % of Revenue | 20.87% | 21.29% | 22.14% | 21.4% | 20.5% | 18.18% | 18.44% | 18.9% | 20.07% | - |
| Research & Development | 1.51B | 1.35B | 1.15B | 1.14B | 1.19B | 1.22B | 1.34B | 1.4B | 1.47B | 1.48B |
| R&D % of Revenue | 10.6% | 9.48% | 8.28% | 8.03% | 7.58% | 6.97% | 7.76% | 8.29% | 8.47% | - |
| Other Operating Expenses | 1.17B | 391M | 475M | 682M | 722M | 702M | 683M | 685M | 0 | 2M |
| Operating Income | 188M▲ 0% | -448M▼ 338.3% | 584M▲ 230.4% | 843M▲ 44.3% | 1.32B▲ 56.2% | 1.93B▲ 46.4% | 2.11B▲ 9.4% | 2.1B▼ 0.7% | 2.62B▲ 25.0% | 2.47B▲ 0% |
| Operating Margin % | 1.32% | -3.14% | 4.22% | 5.93% | 8.41% | 11.05% | 12.25% | 12.4% | 15.05% | 13.82% |
| Operating Income Growth % | - | -338.3% | 230.36% | 44.35% | 56.23% | 46.39% | 9.44% | -0.66% | 24.95% | - |
| EBITDA | 458M | 2.34B | 2.18B | 2.02B | 2.56B | 3.15B | 3.32B | 3.32B | 3.82B | 3.38B |
| EBITDA Margin % | 3.22% | 16.39% | 15.77% | 14.21% | 16.35% | 18.05% | 19.28% | 19.65% | 21.96% | 18.89% |
| EBITDA Growth % | - | 411.35% | -6.79% | -7.47% | 26.73% | 23.09% | 5.4% | 0.06% | 15.02% | -3.81% |
| D&A (Non-Cash Add-back) | 270M | 2.79B | 1.6B | 1.18B | 1.24B | 1.22B | 1.21B | 1.23B | 1.2B | 907M |
| EBIT | -300M | -6.47B | -180M | 720M | 2.38B | 1.5B | 1.33B | 1.51B | 1.87B | 1.05B |
| Net Interest Income | -74M | -251M | -77M | 11M | 47M | 45M | 50M | -101M | -44M | -40M |
| Interest Income | 0 | 86M | 59M | 56M | 77M | 124M | 283M | 132M | 136M | 104M |
| Interest Expense | 74M | 337M | 136M | 45M | 30M | 79M | 233M | 233M | 180M | 180M |
| Other Income/Expense | -562M | -6.36B | -900M | -168M | 1.03B | -502M | -1.02B | -821M | -931M | -711M |
| Pretax Income | -374M▲ 0% | -6.81B▼ 1719.8% | -316M▲ 95.4% | 675M▲ 313.6% | 2.35B▲ 247.6% | 1.43B▼ 39.2% | 1.09B▼ 23.4% | 1.27B▲ 16.7% | 1.69B▲ 32.4% | 1.76B▲ 0% |
| Pretax Margin % | -2.63% | -47.64% | -2.28% | 4.75% | 14.99% | 8.17% | 6.35% | 7.54% | 9.7% | 9.85% |
| Income Tax | -2.52B | -31M | -46M | -81M | 524M | 210M | 152M | 412M | 484M | 500M |
| Effective Tax Rate % | 674.87% | 0.46% | 14.56% | -12% | 22.34% | 14.73% | 13.91% | 32.31% | 28.67% | 28.38% |
| Net Income | 2.53B▲ 0% | -5.07B▼ 299.9% | -959M▲ 81.1% | 681M▲ 171.0% | 1.76B▲ 158.3% | 1.15B▼ 34.8% | 735M▼ 35.9% | 907M▲ 23.4% | 1.09B▲ 20.6% | 1.16B▲ 0% |
| Net Margin % | 17.79% | -35.45% | -6.93% | 4.79% | 11.24% | 6.57% | 4.27% | 5.36% | 6.29% | 6.5% |
| Net Income Growth % | - | -299.88% | 81.07% | 171.01% | 158.3% | -34.79% | -35.92% | 23.4% | 20.62% | 1.93% |
| Net Income (Continuing) | 2.57B | -6.78B | -270M | 756M | 1.82B | 1.22B | 941M | 863M | 1.2B | 1.26B |
| Discontinued Operations | 0 | 1.75B | -671M | -55M | -53M | -58M | -194M | 56M | -99M | -3M |
| Minority Interest | 172M | 493M | 246M | 239M | 239M | 239M | 242M | 241M | 242M | 243M |
| EPS (Diluted) | 3.38▲ 0% | -6.76▼ 300.0% | -1.28▲ 81.1% | 0.91▲ 171.1% | 2.37▲ 160.4% | 1.58▼ 33.3% | 1.03▼ 34.8% | 1.30▲ 26.2% | 1.60▲ 23.1% | 1.73▲ 0% |
| EPS Growth % | - | -300% | 81.07% | 171.09% | 160.44% | -33.33% | -34.81% | 26.21% | 23.08% | 3.63% |
| EPS (Basic) | 3.38 | -6.76 | -1.28 | 0.91 | 2.39 | 1.59 | 1.04 | 1.31 | 1.61 | - |
| Diluted Shares Outstanding | 749.4M | 749.4M | 749.5M | 751.2M | 741.6M | 724.5M | 711.9M | 696M | 673.17M | 673.6M |
| Basic Shares Outstanding | 749.4M | 749.4M | 749.5M | 748.7M | 735.9M | 720.8M | 709M | 693.7M | 673.17M | 672.5M |
| Dividend Payout Ratio | 72.1% | - | - | 56.97% | 22.57% | 36.44% | 59.73% | 50.5% | 43.42% | - |
CTVA Balance Sheet
Corteva, Inc. (CTVA) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 23.05B | 22.97B | 13.52B | 14.77B | 15.55B | 16.8B | 16.26B | 15.1B | 17.34B | 17.39B |
| Cash & Short-Term Investments | 8.76B | 2.27B | 1.77B | 3.79B | 4.54B | 3.31B | 2.74B | 3.17B | 4.53B | 1.97B |
| Cash Only | 7.81B | 2.27B | 1.76B | 3.53B | 4.46B | 3.19B | 2.64B | 3.11B | 4.52B | 1.96B |
| Short-Term Investments | 952M | 5M | 5M | 269M | 86M | 124M | 98M | 63M | 9M | 2M |
| Accounts Receivable | 5.24B | 5.26B | 5.53B | 4.93B | 4.81B | 5.7B | 5.49B | 5.68B | 6.37B | 9.09B |
| Days Sales Outstanding | 134.29 | 134.38 | 145.73 | 126.47 | 112.17 | 119.21 | 116.28 | 122.53 | 133.64 | 162.81 |
| Inventory | 8.63B | 5.31B | 5.03B | 4.88B | 5.18B | 6.81B | 6.9B | 5.43B | 5.67B | 5.2B |
| Days Inventory Outstanding | 375.04 | 194.83 | 214.19 | 209.47 | 205.07 | 238.22 | 253.84 | 208.07 | 210.72 | 267.59 |
| Other Current Assets | 423M | 10.13B | 1.19B | 1.17B | 1.01B | 968M | 1.13B | 820M | 767M | 1.13B |
| Total Non-Current Assets | 89.91B | 85.71B | 28.88B | 27.88B | 26.8B | 25.82B | 26.74B | 25.73B | 25.51B | 25.33B |
| Property, Plant & Equipment | 12.44B | 4.54B | 4.55B | 4.4B | 4.33B | 4.25B | 4.29B | 4.1B | 4.22B | 9.62B |
| Fixed Asset Turnover | 1.15x | 3.14x | 3.05x | 3.23x | 3.62x | 4.10x | 4.02x | 4.12x | 4.12x | 3.22x |
| Goodwill | 45.59B | 10.19B | 10.23B | 10.27B | 10.11B | 9.96B | 10.61B | 10.41B | 10.46B | 10.41B |
| Intangible Assets | 0 | 12.05B | 11.42B | 10.75B | 10.04B | 9.34B | 9.63B | 8.88B | 8.3B | 8.15B |
| Long-Term Investments | 1.59B | 138M | 66M | 66M | 76M | 102M | 115M | 134M | 160M | 435M |
| Other Non-Current Assets | 29.81B | 58.48B | 2.33B | 1.94B | 1.8B | 1.69B | 1.52B | 1.81B | 2.04B | 2.77B |
| Total Assets | 112.96B▲ 0% | 108.68B▼ 3.8% | 42.4B▼ 61.0% | 42.65B▲ 0.6% | 42.34B▼ 0.7% | 42.62B▲ 0.6% | 43B▲ 0.9% | 40.83B▼ 5.0% | 42.84B▲ 4.9% | 42.72B▲ 0% |
| Asset Turnover | 0.13x | 0.13x | 0.33x | 0.33x | 0.37x | 0.41x | 0.40x | 0.41x | 0.41x | 0.42x |
| Asset Growth % | - | -3.79% | -60.99% | 0.59% | -0.72% | 0.65% | 0.89% | -5.05% | 4.95% | 7.76% |
| Total Current Liabilities | 12.14B | 13.31B | 8.24B | 8.55B | 9.56B | 10.74B | 10.41B | 10.39B | 12.13B | 11.85B |
| Accounts Payable | 4.83B | 3.8B | 3.7B | 3.62B | 4.13B | 4.89B | 4.28B | 4.04B | 4.4B | 4.19B |
| Days Payables Outstanding | 209.87 | 139.35 | 157.58 | 155.1 | 163.34 | 171.2 | 157.48 | 154.71 | 163.54 | 218.69 |
| Short-Term Debt | 2.78B | 2.13B | 3M | 3M | 17M | 23M | 197M | 750M | 894M | 1.67B |
| Deferred Revenue (Current) | 2.01B | 2.21B | 2.58B | 2.66B | 3.2B | 3.39B | 3.41B | 3.29B | 3.58B | 7.19B |
| Other Current Liabilities | 2.52B | 3.17B | 381M | 232M | 0 | 0 | 0 | 0 | 0 | 7.41B |
| Current Ratio | 1.90x | 1.73x | 1.64x | 1.73x | 1.63x | 1.56x | 1.56x | 1.45x | 1.43x | 1.43x |
| Quick Ratio | 1.19x | 1.33x | 1.03x | 1.16x | 1.08x | 0.93x | 0.90x | 0.93x | 0.96x | 0.96x |
| Cash Conversion Cycle | 299.45 | 189.86 | 202.34 | 180.83 | 153.9 | 186.23 | 212.65 | 175.89 | 180.82 | 211.7 |
| Total Non-Current Liabilities | 25.89B | 20.22B | 9.6B | 9.04B | 7.16B | 6.33B | 7.31B | 6.41B | 6.33B | 6.26B |
| Long-Term Debt | 10.29B | 5.72B | 115M | 1.1B | 1.1B | 1.28B | 2.29B | 1.95B | 1.69B | 1.68B |
| Capital Lease Obligations | 4M | 67M | 5M | 395M | 3M | 2M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 5.84B | 0 | 920M | 893M | 1.22B | 1.12B | 899M | 478M | 251M | 1.17B |
| Other Non-Current Liabilities | 9.71B | 12.81B | 8.56B | 6.14B | 4.84B | 3.93B | 4.12B | 3.98B | 4.4B | 17.09B |
| Total Liabilities | 38.03B | 33.53B | 17.84B | 17.59B | 16.72B | 17.08B | 17.72B | 16.8B | 18.46B | 18.11B |
| Total Debt | 13.07B | 7.94B | 127M | 1.11B | 1.12B | 1.31B | 2.49B | 2.7B | 2.58B | 3.36B |
| Net Debt | 5.26B | 5.67B | -1.64B | -2.42B | -3.34B | -1.88B | -155M | -403M | -1.94B | 1.39B |
| Debt / Equity | 0.17x | 0.11x | 0.01x | 0.04x | 0.04x | 0.05x | 0.10x | 0.11x | 0.11x | 0.11x |
| Debt / EBITDA | 28.54x | 3.39x | 0.06x | 0.55x | 0.44x | 0.41x | 0.75x | 0.81x | 0.68x | 0.99x |
| Net Debt / EBITDA | 11.49x | 2.42x | -0.75x | -1.20x | -1.30x | -0.60x | -0.05x | -0.12x | -0.51x | -0.51x |
| Interest Coverage | -4.05x | -19.20x | -1.32x | 16.00x | 79.20x | 19.05x | 5.69x | 6.47x | 10.38x | 5.82x |
| Total Equity | 74.93B▲ 0% | 75.15B▲ 0.3% | 24.55B▼ 67.3% | 25.06B▲ 2.1% | 25.62B▲ 2.2% | 25.54B▼ 0.3% | 25.28B▼ 1.0% | 24.03B▼ 4.9% | 24.39B▲ 1.5% | 24.61B▲ 0% |
| Equity Growth % | - | 0.29% | -67.33% | 2.07% | 2.23% | -0.32% | -1.03% | -4.94% | 1.48% | 6.6% |
| Book Value per Share | 99.99 | 100.28 | 32.76 | 33.36 | 34.55 | 35.25 | 35.51 | 34.53 | 36.23 | 36.53 |
| Total Shareholders' Equity | 74.76B | 74.66B | 24.31B | 24.82B | 25.38B | 25.3B | 25.04B | 23.79B | 24.14B | 24.36B |
| Common Stock | 0 | 0 | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 7M |
| Retained Earnings | 175M | 0 | -425M | 0 | 524M | 250M | -41M | 55M | -67M | 436M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -381M | 74.66B | -3.27B | -2.89B | -2.9B | -2.81B | -2.68B | -3.47B | -2.8B | -2.94B |
| Minority Interest | 172M | 493M | 246M | 239M | 239M | 239M | 242M | 241M | 242M | 243M |
CTVA Cash Flow Statement
Corteva, Inc. (CTVA) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 247M | 483M | 1.07B | 2.06B | 2.73B | 872M | 1.77B | 2.15B | 3.41B | 3.41B |
| Operating CF Margin % | 1.73% | 3.38% | 7.73% | 14.52% | 17.42% | 5% | 10.27% | 12.69% | 19.57% | - |
| Operating CF Growth % | - | 95.55% | 121.53% | 92.9% | 32.12% | -68.02% | 102.87% | 21.25% | 58.79% | 126.49% |
| Net Income | 2.71B | -5.07B | -941M | 701M | 1.82B | 1.21B | 941M | 863M | 1.1B | 1.16B |
| Depreciation & Amortization | 1.54B | 2.79B | 1.6B | 1.18B | 1.24B | 1.22B | 1.21B | 1.23B | 1.2B | 1.2B |
| Stock-Based Compensation | 0 | 0 | 84M | 0 | 0 | 55M | 0 | 0 | 0 | 0 |
| Deferred Taxes | -3.02B | 31M | -477M | -330M | 174M | -286M | -438M | -365M | -41M | -2M |
| Other Non-Cash Items | -334M | 5.67B | 1.36B | 19M | -1.17B | 224M | 841M | 512M | 599M | -3.26B |
| Working Capital Changes | -656M | -2.94B | -556M | 497M | 656M | -1.55B | -786M | -92M | 540M | 3.53B |
| Change in Receivables | -162M | -1.52B | 0 | 187M | -113M | -997M | 358M | -705M | -261M | 2.24B |
| Change in Inventory | -1.01B | -498M | 74M | 104M | -422M | -1.72B | 57M | 1.11B | -35M | 25M |
| Change in Payables | 934M | 642M | 149M | -118M | 524M | 807M | -663M | -115M | 231M | 200M |
| Cash from Investing | 386M | -505M | -904M | -674M | -362M | -632M | -1.99B | -589M | -543M | -586M |
| Capital Expenditures | -1.11B | -1.5B | -1.16B | -475M | -573M | -605M | -595M | -597M | -591M | -578M |
| CapEx % of Revenue | 7.82% | 10.51% | 8.4% | 3.34% | 3.66% | 3.47% | 3.45% | 3.53% | 3.4% | - |
| Acquisitions | 1.32B | 0 | 1M | -10M | -4M | -12M | -1.46B | -7M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -214M | 75M | 236M | 85M | 74M | 34M | 45M | -34M | 37M | 48M |
| Cash from Financing | 2.4B | -2.62B | -2.93B | 303M | -1.27B | -1.18B | -99M | -1.2B | -1.64B | -2.25B |
| Debt Issued (Net) | 4.03B | -4.8B | -7.67B | 998M | 11M | 205M | 1.11B | 240M | -141M | -1.51B |
| Equity Issued (Net) | 265M | 0 | -25M | -275M | -950M | -1B | -756M | -1.01B | -983M | -783M |
| Dividends Paid | -988M | -2.81B | -511M | -388M | -397M | -418M | -439M | -458M | -475M | -480M |
| Share Repurchases | 0 | 0 | -25M | -275M | -950M | -1B | -756M | -1.01B | -1.07B | -1.05B |
| Other Financing | -903M | 4.98B | 5.28B | -32M | 70M | 33M | -18M | 28M | -45M | 522M |
| Net Change in Cash | 3.2B▲ 0% | -2.89B▼ 190.2% | -2.85B▲ 1.3% | 1.7B▲ 159.6% | 963M▼ 43.4% | -1.22B▼ 226.5% | -460M▲ 62.2% | 264M▲ 157.4% | 1.1B▲ 316.3% | -358M▲ 0% |
| Free Cash Flow | -866M▲ 0% | -1.02B▼ 17.6% | -93M▲ 90.9% | 1.59B▲ 1808.6% | 2.15B▲ 35.6% | 267M▼ 87.6% | 1.17B▲ 339.7% | 1.55B▲ 31.9% | 2.81B▲ 81.8% | 2.05B▲ 0% |
| FCF Margin % | -6.08% | -7.13% | -0.67% | 11.18% | 13.76% | 1.53% | 6.82% | 9.16% | 16.18% | 11.47% |
| FCF Growth % | - | -17.55% | 90.86% | 1808.6% | 35.56% | -87.6% | 339.7% | 31.86% | 81.85% | -2.38% |
| FCF per Share | -1.16 | -1.36 | -0.12 | 2.12 | 2.90 | 0.37 | 1.65 | 2.22 | 4.18 | 4.18 |
| FCF Conversion (FCF/Net Income) | 0.10x | -0.10x | -1.12x | 3.03x | 1.55x | 0.76x | 2.41x | 2.36x | 3.11x | 1.77x |
| Interest Paid | 0 | 923M | 263M | 36M | 30M | 75M | 234M | 244M | 191M | 0 |
| Taxes Paid | 0 | 961M | 234M | 229M | 341M | 467M | 535M | 707M | 750M | 0 |
CTVA Key Ratios
Corteva, Inc. (CTVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -6.75% | -1.92% | 2.74% | 6.94% | 4.48% | 2.89% | 3.68% | 4.52% | 4.62% |
| Return on Invested Capital (ROIC) | -0.42% | 0.84% | 2.78% | 4.4% | 6.3% | 6.49% | 6.45% | 8.53% | 8.53% |
| Gross Margin | 30.37% | 38.07% | 40.16% | 41.11% | 40.21% | 42.41% | 43.64% | 43.59% | 33.51% |
| Net Margin | -35.45% | -6.93% | 4.79% | 11.24% | 6.57% | 4.27% | 5.36% | 6.29% | 6.5% |
| Debt / Equity | 0.11x | 0.01x | 0.04x | 0.04x | 0.05x | 0.10x | 0.11x | 0.11x | 0.11x |
| Interest Coverage | -19.20x | -1.32x | 16.00x | 79.20x | 19.05x | 5.69x | 6.47x | 10.38x | 5.82x |
| FCF Conversion | -0.10x | -1.12x | 3.03x | 1.55x | 0.76x | 2.41x | 2.36x | 3.11x | 1.77x |
| Revenue Growth | 0.33% | -3.09% | 2.68% | 10.11% | 11.5% | -1.31% | -1.85% | 2.92% | 6.27% |
CTVA SEC Filings & Documents
Corteva, Inc. (CTVA) SEC filings — annual & quarterly reports (10-K, 10-Q)
CTVA Frequently Asked Questions
Corteva, Inc. (CTVA) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Corteva, Inc. (CTVA) reported $17.89B in revenue for fiscal year 2025. This represents a 26% increase from $14.24B in 2017.
Corteva, Inc. (CTVA) grew revenue by 2.9% over the past year. Growth has been modest.
Yes, Corteva, Inc. (CTVA) is profitable, generating $1.16B in net income for fiscal year 2025 (6.3% net margin).
Dividend & Returns
Yes, Corteva, Inc. (CTVA) pays a dividend with a yield of 0.84%. This makes it attractive for income-focused investors.
Corteva, Inc. (CTVA) has a return on equity (ROE) of 4.5%. This is below average, suggesting room for improvement.
Corteva, Inc. (CTVA) generated $2.05B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
Explore More CTVA
Corteva, Inc. (CTVA) financial analysis — history, returns, DCA and operating performance tools
Full CTVA Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates